Safety and efficacy of HepaSphere 50-100 μm in the treatment of hepatocellular carcinoma. [electronic resource]
- Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy Aug 2017
- 212-219 p. digital
Publication Type: Journal Article
1365-2931
10.1080/13645706.2017.1288142 doi
Adult Aged Aged, 80 and over Carcinoma, Hepatocellular--drug therapy Chemoembolization, Therapeutic--adverse effects Combined Modality Therapy Doxorubicin--administration & dosage Drug Delivery Systems--methods Female Humans Liver Neoplasms--drug therapy Male Microspheres Middle Aged Prospective Studies